Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan A Alhazmi

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Analytical Techniques for the Characterization and Quantification of Monoclonal AntibodiesHassan A Alhazmi, Mohammed Albratty
Methods (San Diego, Calif.)|February 14, 2018
Thermophoresis for characterizing biomolecular interactionMufarreh Asmari, Ratih Ratih, Hassan A Alhazmi, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic AgentsAsim Najmi, Sadique A Javed, Mohammed Al Bratty, et al.
Drug Discoveries & Therapeutics|April 28, 2020
Treatment of SARS-CoV-2: How far have we reached?Waquar Ahsan, Shamama Javed, Mohammed Al Bratty, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2018
Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MSMohamed W Attwa, Hany W Darwish, Hassan A Alhazmi, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 16, 2022
Perception of Individuals with Diabetes about Efficacy and Safety of Complementary and Alternative Medicines (CAM) in the Jazan Region, Saudi ArabiaAbdulkarim M Meraya, Waquar Ahsan, Mohammed Albratty, et al.
Drug Design, Development and Therapy|March 12, 2020
Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity StudiesMohamed W Attwa, Adnan A Kadi, Ali S Abdelhameed, et al.
International Journal of Medicinal Chemistry|June 29, 2017
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic DrugsNeelaveni Thangavel, Mohammed Al Bratty, Sadique Akhtar Javed, et al.
Current Drug Discovery Technologies|March 2, 2018
Critical Insight into the Design of PPAR-γ Agonists by Virtual Screening TechniquesNeelaveni Thangavel, Mohammed Al Bratty, Sadique Akhtar Javed, et al.
Acta Pharmaceutica (Zagreb, Croatia)|June 8, 2017
Comparing monolithic and fused core HPLC columns for fast chromatographic analysis of fat-soluble vitaminsSaid El Kurdi, Dina Abu Muaileq, Hassan A Alhazmi, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Analytical Techniques for the Characterization and Quantification of Monoclonal AntibodiesHassan A Alhazmi, Mohammed Albratty
Methods (San Diego, Calif.)|February 14, 2018
Thermophoresis for characterizing biomolecular interactionMufarreh Asmari, Ratih Ratih, Hassan A Alhazmi, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic AgentsAsim Najmi, Sadique A Javed, Mohammed Al Bratty, et al.
Drug Discoveries & Therapeutics|April 28, 2020
Treatment of SARS-CoV-2: How far have we reached?Waquar Ahsan, Shamama Javed, Mohammed Al Bratty, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2018
Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MSMohamed W Attwa, Hany W Darwish, Hassan A Alhazmi, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 16, 2022
Perception of Individuals with Diabetes about Efficacy and Safety of Complementary and Alternative Medicines (CAM) in the Jazan Region, Saudi ArabiaAbdulkarim M Meraya, Waquar Ahsan, Mohammed Albratty, et al.
Drug Design, Development and Therapy|March 12, 2020
Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity StudiesMohamed W Attwa, Adnan A Kadi, Ali S Abdelhameed, et al.
International Journal of Medicinal Chemistry|June 29, 2017
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic DrugsNeelaveni Thangavel, Mohammed Al Bratty, Sadique Akhtar Javed, et al.
Current Drug Discovery Technologies|March 2, 2018
Critical Insight into the Design of PPAR-γ Agonists by Virtual Screening TechniquesNeelaveni Thangavel, Mohammed Al Bratty, Sadique Akhtar Javed, et al.
Acta Pharmaceutica (Zagreb, Croatia)|June 8, 2017
Comparing monolithic and fused core HPLC columns for fast chromatographic analysis of fat-soluble vitaminsSaid El Kurdi, Dina Abu Muaileq, Hassan A Alhazmi, et al.
Pageof 10